Cite

    Mitsui, J. et al. (2022). Randomized, double‐blind, placebo‐controlled phase 1 study to evaluate the safety and pharmacokinetics of high doses of ubiquinol in healthy adults. Neurology and clinical neuroscience. 10 (1), pp. 14-24. [Online].